F 0690
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide appropriate care for residents who are continent or incontinent of bowel/bladder, appropriate
catheter care, and appropriate care to prevent urinary tract infections.
Based on observation, interview, and record review, the facility failed to ensure a resident's indwelling
urinary catheter bag included a privacy cover and the catheter tubing was off the floor for one (R22) of one
resident reviewed for indwelling urinary catheters in a sample of 26.
Findings include:
The facility's undated Catheter Care policy documents, Policy: It is the policy of this facility to ensure that
residents with indwelling catheters receive appropriate catheter care and maintain their dignity and privacy
when indwelling catheters are in use. Policy Explanation: 2. Privacy bags will be available and catheter
drainage bags will be covered at all times while in use.
R22's current Physician Order Sheet/POS documents R22 has an indwelling urinary catheter due to urinary
retention.
On 11/12/24, at 10:23am, R22 sat in his room with no privacy cover on his indwelling urinary catheter bag.
On 11/12/24, at 12:40pm, R22 sat at a dining room table with no privacy bag on his indwelling urinary
catheter bag and the catheter tubing was touching the floor.
On 11/12/24, at 1:07pm, V6 Certified Nursing Assistant/CNA confirmed that R22's indwelling catheter bag
is not in a privacy bag and should be covered. V6 also confirmed that R22's catheter tubing was touching
the floor and should not be.
On 11/13/24, at 8:30am and 11:58am, R22 sat at a dining room table with an indwelling catheter bag
hanging underneath his wheelchair. R22's catheter bag did not contain a privacy covering.
On 11/14/24, at 1:21pm, V2 Director of Nursing/DON stated that catheter bags are to be covered with
privacy covers and catheter tubing should not be touching the floor.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
145151
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145151
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/15/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Allure of Mendota
1201 First Avenue
Mendota, IL 61342
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility failed to ensure medications were
administered according to physician orders and medication instructions for two (R6 and R56) of seven
residents reviewed during Medication Administration. This failure resulted in two medication errors out of 26
opportunities resulting in a 7.69% (percent) medication error rate.
Residents Affected - Few
Findings include:
The facility's undated Medication Administration policy documents, Policy: Medications are administered by
licensed nurses, or other staff who are legally authorized to do so in this state, as ordered by the physician
and in accordance with professional standards of practice, in a manner to prevent contamination or
infection. Policy Explanation and compliance Guidelines: 10. Ensure that the six rights of medication
administration are followed: a. Right resident b. Right drug c. Right dosage d. Right route e. Right time f.
Right documentation.
1. On 11/13/24, at 8:45am, R56 sat on her bed. V5 Registered Nurse/RN administered Vitamin D 25mcg
(micrograms) one tablet to R56.
R56's current Physician Order Sheet/POS documents an order for Vitamin D3 oral tablet give 125mcg by
mouth in the morning.
On 11/13/24, at 2:40pm, V5 RN confirmed that V5 gave the wrong medication to R56, that V5 pulled the
wrong Vitamin D from the drawer of the medication cart.
2. On 11/13/24, at 9:04am, R6 was in bed. V4 RN gave R6 his Albuterol inhaler in which R6 inhaled two
puffs orally. Next V4 gave R6 his Arnuity Ellipta 50mcg (micrograms) inhaler and R6 inhaled one puff orally.
This inhaler was followed by his Stiolto 2.5mg (milligrams) inhaler in which R6 inhaled two puffs. V4 took
the three inhalers and left R6's room.
R6's current Physician Order Sheet/POS documents an order for Arnuity Ellipta Inhalation Aerosol Powder
Breath Activated 50 mcg/act (micrograms/actuation) (Fluticasone Furoate (Inhalation) one puff inhale orally
in the morning related to Chronic Obstructive Pulmonary Disease, Unspecified.
The facility's undated Full Prescribing Information for Arnuity Ellipta documents Dosage and Administration:
Administration: After inhalation, the patient should rinse his/her mouth with water without swallowing to help
reduce the risk of oropharyngeal candidiasis.
On 11/13/24, at 2:43pm, V4 RN confirmed that V4 should have had R6 rinse and spit after inhaling the
Arnuity Ellipta as it is a steroid.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145151
If continuation sheet
Page 2 of 2